Oct 25, 2017 7:00am EDT NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017
Oct 24, 2017 9:00am EDT NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials
Oct 12, 2017 4:01pm EDT NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance